How would you approach incorporating immunotherapy in neoadjuvant treatment for GE junction and Gastric cancer?  

Patients with deficient mismatch repair (dMMR) and microsatellite instability high (MSI-H) harbor high tumor mutational burden which tends to have favorable response rates to immune checkpoint inhibitors. 



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Cancer Center Overlook Hospital
In addition, there is data to suggest that giving ...
Sign in or Register to read more